Announced Mon, 13 Jul · 16:03 IST
SEBI Regulation 74(5) certificate filed for quarter ended June 2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹17.10
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.4-4.4-4.4—-9.1—————
Up moveDown movePending
AI summary
Omkar Pharmachem has submitted a routine SEBI Regulation 74(5) certificate for the quarter ended June 30, 2026. The certificate was issued by Alankit Assignments Limited, the company Registrar and Share Transfer Agent, confirming that securities received for dematerialisation were verified, listed on stock exchanges, and the physical certificates cancelled with the depository recorded as the registered owner. This is standard quarterly compliance, not a corporate action.
Likely market impact
Routine regulatory filing, no impact on shareholders or stock price.